Related Experiment Videos
Striatal neurochemical changes and motor dysfunction in mipafox-treated animals
Methods and Findings in Experimental and Clinical Pharmacology
|February 1, 1985
Summary
Daily administration of mipafox in rats for 60 days caused motor dysfunction, including muscle twitching and ataxia. This was linked to reduced levels of key neurochemicals like dopamine and GABA in the corpus striatum.
Area of Science:
- Neuroscience
- Toxicology
- Pharmacology
Background:
- Organophosphate compounds can exhibit neurotoxic effects.
- Neurotransmitter imbalances are implicated in motor control disorders.
Purpose of the Study:
- To investigate the neurotoxic effects of mipafox in a rat model.
- To correlate motor dysfunction with neurochemical changes in the corpus striatum.
Main Methods:
- Rats were administered 5 mg/kg mipafox subcutaneously daily for 60 days.
- Motor function was assessed, and neurochemical levels (cholinesterase, neurotoxicesterase, dopamine, GABA) in the corpus striatum were measured.
Main Results:
- Mipafox treatment led to observable motor dysfunction, including muscle twitching, fasciculations, and ataxia.
- Significant reductions in cholinesterase, neurotoxicesterase, dopamine, and GABA levels were detected in the corpus striatum of treated rats.
Conclusions:
- Subcutaneous administration of mipafox induces motor deficits in rats.
- Neurochemical alterations in the corpus striatum, particularly reduced dopamine and GABA, are associated with mipafox-induced motor dysfunction.